Nutrition in paediatric human immunodeficiency virus infection
Related Experiment Video
Updated: Oct 16, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
1University of Rochester Medical Center, Children's Hospital at Strong, 601 Elmwood Avenue, Box 667, Rochester, NY 14642, USA. tracie_miller@urmc.rochester.edu
Insights
Children with human immunodeficiency virus (HIV) infection experience growth problems due to various factors. New nutritional issues like lipodystrophy are emerging with advanced HIV treatments.
Area of Science:
- Pediatrics
- Infectious Diseases
- Nutrition Science
Background:
- Nutritional status is a significant challenge for children with human immunodeficiency virus (HIV) infection globally.
- HIV-infected children exhibit impaired growth in height and weight compared to uninfected peers, a pattern that persists over time.
- Factors such as infections, increased viral load, poor diet, malabsorption, and psychosocial issues contribute to growth deficits.
Purpose of the Study:
- To review the nutritional challenges faced by children with HIV.
- To discuss the impact of evolving antiretroviral therapies on the nutritional status of HIV-infected children.
- To highlight emerging nutritional complications associated with HIV treatment.
Main Methods:
- Literature review and synthesis of existing research on HIV and child nutrition.
- Analysis of growth patterns in HIV-infected versus HIV-exposed, uninfected children.
- Examination of the relationship between HIV disease progression, treatment regimens, and nutritional outcomes.
Main Results:
- HIV-infected children demonstrate consistently poorer growth parameters (height and weight) than controls.
- Acute infections and higher HIV viral load are associated with decreased growth.
- Antiretroviral therapies, while extending lifespan, have introduced new nutritional problems like lipodystrophy, insulin resistance, and obesity.
Conclusions:
- Growth faltering is a persistent issue in pediatric HIV, influenced by multifactorial causes.
- Modern antiretroviral treatments have shifted nutritional concerns towards metabolic complications, including fat redistribution and potential cardiovascular risks.
- Comprehensive nutritional management is crucial for improving long-term health outcomes in children living with HIV.
Abstract:
The nutritional condition of children with human immunodeficiency virus (HIV) infection continues to be a problem both in developed and developing countries. HIV-infected children grow below normal standards in both height and weight when compared with HIV-exposed non-infected children. These patterns persist over time. It is possible that acute infectious episodes and increased HIV viral burden contribute to decrements in all growth variables. Potential aetiologies for abnormal growth include inadequate dietary intake, gastrointestinal malabsorption, increased energy utilization and psycho-social problems. It is likely that all these factors contribute to the growth problems of these children to some extent. With the development of protease inhibitor anti-retroviral therapy and highly-active anti-retroviral treatment regimens, children with HIV infection in developed countries are living longer with a chronic illness. New nutritional problems have arisen with the development of the fat redistribution syndrome or lipodystrophy. Emerging problems are now being recognized, with the development of insulin resistance and truncal obesity which may potentially lead to premature cardiovascular disease.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Inhibitors of Virion Maturation and Assembly

